Work

Dramatic Response to Lorlatinib in a Patient With CD74-ROS1-Positive Lung Adenocarcinoma With Acquired F2004V Mutation

Year: 2019

Type: article

Source: JCO Precision Oncology

DOI: 10.1200/po.19.00013

Authors: Anastasios Dimou, Sai-Hong I. Ou, Robert C. Doebele

Institutions: University of Colorado Anschutz, University of Colorado Denver, University of California, Irvine

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Funder: Pfizer

OpenAlex ID: W2948856571

FWCI: 1.103

Cites: 36

Cited by: 8

Related to: 10